Related Experiment Video
Updated: Aug 23, 2025

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
Published on: July 3, 2020
Bayesian Method of Borrowing Study-Level Historical Longitudinal Control Data for Mixed-Effects Models with Repeated
Hong Li1, Man Jin2, Yu-Che Chung2
1Statistical & Quantitative Sciences, Takeda Pharmaceuticals U.S.A., Inc., Lexington, USA. hong.li@takeda.com.
Abstract:
Bringing historical control information into a new trial appropriately holds the promise of more efficient trial design with more accurate estimates, increased power, and fewer patients allocated to inefficacious control group, provided the historical control data are sufficiently similar to the concurrent control. Interest has been growing over the past few decades in leveraging historical clinical trial on the control arm. However, most of the current historical borrowing methods focus on incorporating patient-level historical control information at only one time point. In this work, we propose a Bayesian hierarchical Mixed effect Models for Repeated Measures to incorporate aggregated study-level longitudinal historical control estimates into the concurrent trial that collected repeated longitudinal data. The simulation study demonstrates that, as compared to one time point data analysis approach, leveraging longitudinal historical control data produces greater power enhancement and mitigates the power loss when the missing data under missing at random mechanism is present. Our work also helps fill the gap of lack of methods borrowing historical longitudinal control data from the published summarized estimates when patient-level control data are not available.
More Related Videos
Related Concept Videos
Longitudinal Research
Mechanistic Models: Compartment Models in Individual and Population Analysis
Longitudinal Studies
Cross-Sectional Research
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Analysis of Population Pharmacokinetic Data

